2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery …

G Hindricks, T Potpara, N Dagres, E Arbelo… - European heart …, 2021 - academic.oup.com
MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

Molecular basis of atrial fibrillation pathophysiology and therapy: a translational perspective

S Nattel, J Heijman, L Zhou, D Dobrev - Circulation research, 2020 - Am Heart Assoc
Atrial fibrillation (AF) is a highly prevalent arrhythmia, with substantial associated morbidity
and mortality. There have been significant management advances over the past 2 decades …

Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference

RB Schnabel, EA Marinelli, E Arbelo, G Boriani… - Europace, 2023 - academic.oup.com
Despite marked progress in the management of atrial fibrillation (AF), detecting AF remains
difficult and AF-related complications cause unacceptable morbidity and mortality even on …

Atrial cardiomyopathy revisited—evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart …

A Goette, D Corradi, D Dobrev, L Aguinaga… - Europace, 2024 - academic.oup.com
Aims The concept of “atrial cardiomyopathy”(AtCM) had been percolating through the
literature since its first mention in 1972. Since then, publications using the term were …

Practical approach for atrial cardiomyopathy characterization in patients with atrial fibrillation

G La Rosa, CA Morillo, JG Quintanilla, A Doltra… - Revista Española de …, 2024 - Elsevier
Atrial fibrillation (AF) causes progressive structural and electrical changes in the atria that
can be summarized within the general concept of atrial remodeling. In parallel, other clinical …

Comparison of various late gadolinium enhancement magnetic resonance imaging methods with high-definition voltage and activation map** for detection of atrial …

M Eichenlaub, B Mueller-Edenborn, J Minners… - EP …, 2022 - academic.oup.com
Aims Atrial cardiomyopathy (ACM) is associated with increased arrhythmia recurrence rates
after pulmonary vein isolation (PVI). We compare the most common left atrial (LA) late …

2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement …

S Tzeis, EP Gerstenfeld, J Kalman, EB Saad… - Europace, 2024 - academic.oup.com
In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based
safe and efficacious treatment for managing the most common cardiac arrhythmia. In 2007 …

Left atrial cardiomyopathy–a challenging diagnosis

F Kreimer, M Gotzmann - Frontiers in Cardiovascular Medicine, 2022 - frontiersin.org
Left atrial cardiomyopathy (LACM) has been an ongoing focus of research for several years.
There is evidence that LACM is responsible for atrial fibrillation and embolic strokes of …

P-wave duration and atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis

S Intzes, K Zagoridis, M Symeonidou… - Europace, 2023 - academic.oup.com
Aims Atrial fibrillation (AF) is a global health problem with high morbidity and mortality.
Catheter ablation (CA) can reduce AF burden and symptoms, but AF recurrence (AFr) …

Abnormal conduction zone detected by isochronal late activation map** accurately identifies the potential atrial substrate and predicts the atrial fibrillation ablation …

MJ Kuo, ANK Ton, LW Lo, YJ Lin… - Circulation …, 2023 - Am Heart Assoc
Background: The presence of abnormal substrate of left atrium is a predictor of atrial
fibrillation (AF) recurrence after pulmonary vein isolation. We aimed to investigate the …